ReviewBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir.
Paul Andrei Negru et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it